2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Abstract Number: 1527

Anxiety Sensitivity on Indicators of Disease Severity Among Patients with Inflammatory Arthritis
Abstract Number: 1528

Incretin Axis in Non Diabetic Rheumatoid Arthritis Patients
Abstract Number: 1529

Serum Levels of P-Glycoprotein Are Associated with Disease Activity in Rheumatoid Arthritis
Abstract Number: 1530

Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study
Abstract Number: 1531

Decrease in Bone Mineral Density during Three Months of Early RA Measured By DXR Predicts Radiographic Joint Damage after One Year
Abstract Number: 1532

Sleep Hygiene Practices and Associations with Patient-Reported Outcomes in Rheumatoid Arthritis
Abstract Number: 1533

Pregnancy Outcomes in Women with Rheumatoid Arthritis : A Systematic Review and Meta-Analyses
Abstract Number: 1534

Assessment of the Relationship of the Static and Dynamic Balance Parameters with Clinical, Functional and Radiological Findings in Patients with Rheumatoid Arthritis
Abstract Number: 1535

Depression in Rheumatoid Arthritis
Abstract Number: 1536

Sleep Disturbance in Patients with Rheumatoid Arthritis – a Cross-Section Study
Abstract Number: 1537

Prevalence and Impact of Inflammatory Multimorbid Conditions on Trajectories of Disease Activity in the First Year of Follow-up in a Multi-Center Era Cohort
Abstract Number: 1538

Lower Ratings of Pain Intensity in Older Adults Lead to Underestimation of Disease Activity By Disease Activity Score 28-C-Reactive Protein (DAS28-CRP) in Patients with Rheumatoid Arthritis
Abstract Number: 1539

Physician-Reported and Patient-Reported Anxiety and Depression in Rheumatoid Arthritis
Abstract Number: 1540

“I Am Always in Pain Somewhere”: Continuing Unmet Need in Rheumatoid Arthritis
Abstract Number: 1541

Frailty Is Associated with Decreased Physical Function in Adults with Rheumatoid Arthritis

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].